Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Imaida, K.
Right arrow Articles by Shirai, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imaida, K.
Right arrow Articles by Shirai, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 3, 467-472, March 2001
© 2001 Oxford University Press


CARCINOGENESIS

Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis

K. Imaida1,5, S. Tamano1, K. Kato1, Y. Ikeda1, M. Asamoto1, S. Takahashi1, Z. Nir2, M. Murakoshi3, H. Nishino4 and T. Shirai1

1 1st Department of Pathology Nagoya City University Medical School, 1-Kawasumi, Mizuho-ku, Nagoya 467-8601, Japan,
2 LycoRed Natural Products Industries Ltd, Beer-Sheva 84102, Israel,
3 Lion Corp., 7-13-12 Hirai, Edogawa-ku, Tokyo 132-0035, Japan and
4 Department of Biochemistry, Kyoto Prefectural University of Medicine, Kajii-cho, Kawaramachidori, Kyoto 602-8566, Japan

The chemopreventive efficacy of lycopene and curcumin with regard to prostate carcinogenesis was investigated using 3,2'-dimethyl-4-aminobiphenol (DMAB)- and 2-amino-1-methylimidazo[4,5-b]pyridine (PhIP)-induced rat ventral prostate cancer models. Three 60 week experiments with male F344 rats were carried out. In the first DMAB was given for the first 20 weeks and lycopene or curcumin were administered concomitantly or subsequently at dietary doses of 15 and 500 p.p.m., respectively. In the second experiment lycopene and curcumin were given to rats pretreated with DMAB at doses of 5, 15 or 45 p.p.m. or 100 or 500 p.p.m. In the third PhIP was selected as an initiator for prostate carcinogenesis and administered for 20 weeks. Rats were then fed a diet containing lycopene at a dose of 45 p.p.m. or curcumin at a dose of 500 p.p.m. or both together. Chemopreventive effects of lycopene and curcumin on development of DMAB-induced ventral prostate carcinomas were observed only in the first experiment and no confirmation of inhibition potential was obtained in the following studies. Neither summational nor synergistic chemoprevention was evident. It is concluded from the present data that, overall, neither lycopene nor curcumin can consistently prevent rat prostate carcinogenesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Nutr.Home page
J. Limpens, F. H. Schroder, C. M. A. de Ridder, C. A. Bolder, M. F. Wildhagen, U. C. Obermuller-Jevic, K. Kramer, and W. M. van Weerden
Combined Lycopene and Vitamin E Treatment Suppresses the Growth of PC-346C Human Prostate Cancer Cells in Nude Mice
J. Nutr., May 1, 2006; 136(5): 1287 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. O. Khor, Y.-S. Keum, W. Lin, J.-H. Kim, R. Hu, G. Shen, C. Xu, A. Gopalakrishnan, B. Reddy, X. Zheng, et al.
Combined Inhibitory Effects of Curcumin and Phenethyl Isothiocyanate on the Growth of Human PC-3 Prostate Xenografts in Immunodeficient Mice
Cancer Res., January 15, 2006; 66(2): 613 - 621.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. D. Davis, C. A. Swanson, R. G. Ziegler, B. Clevidence, J. T. Dwyer, and J. A. Milner
Executive Summary Report
J. Nutr., August 1, 2005; 135(8): 2014S - 2029S.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. K. Clinton
Tomatoes or Lycopene: a Role in Prostate Carcinogenesis?
J. Nutr., August 1, 2005; 135(8): 2057S - 2059S.
[Full Text] [PDF]


Home page
J. Nutr.Home page
L. Tang, T. Jin, X. Zeng, and J.-S. Wang
Lycopene Inhibits the Growth of Human Androgen-Independent Prostate Cancer Cells In Vitro and in BALB/c Nude Mice
J. Nutr., February 1, 2005; 135(2): 287 - 290.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. W. Hadley, E. C. Miller, S. J. Schwartz, and S. K. Clinton
Tomatoes, Lycopene, and Prostate Cancer: Progress and Promise
Experimental Biology and Medicine, November 1, 2002; 227(10): 869 - 880.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
T. W.-M. Boileau, A. C. Boileau, and J. W. Erdman Jr
Bioavailability of all-trans and cis-Isomers of Lycopene
Experimental Biology and Medicine, November 1, 2002; 227(10): 914 - 919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
J. D. Brooks, M. F. Goldberg, L. A. Nelson, D. Wu, and W. G. Nelson
Identification of Potential Prostate Cancer Preventive Agents through Induction of Quinone Reductase in Vitro
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 868 - 875.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
E. Kotake-Nara, M. Kushiro, H. Zhang, T. Sugawara, K. Miyashita, and A. Nagao
Carotenoids Affect Proliferation of Human Prostate Cancer Cells
J. Nutr., December 1, 2001; 131(12): 3303 - 3306.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.